A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
Scope of the Report:
This report focuses on the Spinal Cord Stimulation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of spinal cord stimulation devices includes rechargeable type and Non-Rechargeable type. The proportion of rechargeable type in 2017 is about 66%, and the proportion is in increasing trend from 2013 to 2017.
Spinal cord stimulation devices is widely used in failed back surgery syndrome, complex regional pain syndrome, chronic pain and other field. The most proportion of spinal cord stimulation devices is for failed back surgery syndrome, and the proportion in 2017 is 42%.
North America is the largest supplier of Spinal Cord Stimulation Devices, with a production market share nearly 87% in 2017. Europe is the second largest supplier of Spinal Cord Stimulation Devices, enjoying production market share nearly 13% in 2017.
North America is the largest consumption place, with a consumption market share nearly 57% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro,
Nuvectra are the leaders of the industry. and Top 3 account for around 78% of the total market share. These existing companies are making investments in several research activities to launch new devices.
The worldwide market for Spinal Cord Stimulation Devices is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 2980 million US$ in 2023, from 2150 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Boston Scientific
- Abbott (St. Jude Medical)
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Failed Back Surgery Syndrome
- Complex Regional Pain Syndrome
- Chronic Pain
There are 15 Chapters to deeply display the global Spinal Cord Stimulation Devices market.
Chapter 1, to describe Spinal Cord Stimulation Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Spinal Cord Stimulation Devices, with sales, revenue, and price of Spinal Cord Stimulation Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Spinal Cord Stimulation Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Spinal Cord Stimulation Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Spinal Cord Stimulation Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source